If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Data Management and Biostatics
Download FREE Excerpt
22 Info Graphics
23 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
As the pharmaceutical industry's use of real world data rises, regulators, payers, physicians and patients are increasingly expecting pharma companies to demonstrate the effectiveness of new medicines. Pharmaceutical companies, in turn, are relying on their Medical Affairs function to oversee the collection and utilization of real world data for informing key stakeholders on product effectiveness.
However, it is challenging for Medical Affairs groups to harness relevant information from huge data sources such as electronic medical records, clinical trial data, and patient behavior data. Equally difficult is the task of assimilating this information in a way that presents a clear outcomes picture in terms of cause and effect.
Best Practices, LLC undertook benchmarking research to understand Medical Affairs' role in the collection, analysis and dissemination of RWD. Additionally, this study probes the pros and cons of various forms of RWD and lessons learned in utilizing it.
This study includes two segments: Regional Segment: US-Only (N= 8), Global (N= 12) and Company-Size Segments: Large Companies (N= 18) and Small and Mid-sized Companies (N= 10).
Best Practices, LLC engaged 28 Medical Affairs leaders from 23 leading biopharmaceutical companies through a benchmarking survey. More than 75% of participants serve at the director level or above.